These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33928584)

  • 21. Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles-cell-penetrating peptide.
    Dowaidar M; Nasser Abdelhamid H; Hällbrink M; Langel Ü; Zou X
    J Biomater Appl; 2018 Sep; 33(3):392-401. PubMed ID: 30223733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect.
    Veldhoen S; Laufer SD; Trampe A; Restle T
    Nucleic Acids Res; 2006; 34(22):6561-73. PubMed ID: 17135188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cationic cell-penetrating peptides as vehicles for siRNA delivery.
    Beloor J; Zeller S; Choi CS; Lee SK; Kumar P
    Ther Deliv; 2015; 6(4):491-507. PubMed ID: 25996046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.
    Zeller S; Choi CS; Uchil PD; Ban HS; Siefert A; Fahmy TM; Mothes W; Lee SK; Kumar P
    Chem Biol; 2015 Jan; 22(1):50-62. PubMed ID: 25544044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake.
    Jafari M; Xu W; Naahidi S; Chen B; Chen P
    J Phys Chem B; 2012 Nov; 116(44):13183-91. PubMed ID: 23077976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. siRNA delivery: from lipids to cell-penetrating peptides and their mimics.
    Gooding M; Browne LP; Quinteiro FM; Selwood DL
    Chem Biol Drug Des; 2012 Dec; 80(6):787-809. PubMed ID: 22974319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
    Zhang C; Yuan W; Wu Y; Wan X; Gong Y
    Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
    Furukawa K; Tanaka M; Oba M
    Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery.
    Margus H; Padari K; Pooga M
    Mol Ther; 2012 Mar; 20(3):525-33. PubMed ID: 22233581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery.
    Nam HY; Kim J; Kim S; Yockman JW; Kim SW; Bull DA
    Biomaterials; 2011 Aug; 32(22):5213-22. PubMed ID: 21501867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of Lipid-Conjugated siRNA Oligonucleotides for Enhanced Gene Inhibition in Mammalian Cells.
    Grijalvo S; Ocampo SM; Perales JC; Eritja R
    Methods Mol Biol; 2021; 2282():119-136. PubMed ID: 33928573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells.
    Liu L; Li H; Zhang M; Lv X
    Int J Clin Exp Pathol; 2015; 8(6):6674-82. PubMed ID: 26261549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-penetrating peptides for siRNA delivery to glioblastomas.
    Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
    Peptides; 2018 Jun; 104():62-69. PubMed ID: 29684592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.
    Andaloussi SE; Lehto T; Mäger I; Rosenthal-Aizman K; Oprea II; Simonson OE; Sork H; Ezzat K; Copolovici DM; Kurrikoff K; Viola JR; Zaghloul EM; Sillard R; Johansson HJ; Said Hassane F; Guterstam P; Suhorutšenko J; Moreno PM; Oskolkov N; Hälldin J; Tedebark U; Metspalu A; Lebleu B; Lehtiö J; Smith CI; Langel U
    Nucleic Acids Res; 2011 May; 39(9):3972-87. PubMed ID: 21245043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing.
    Baoum A; Ovcharenko D; Berkland C
    Int J Pharm; 2012 May; 427(1):134-42. PubMed ID: 21856394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A convergent uptake route for peptide- and polymer-based nucleotide delivery systems.
    Lindberg S; Regberg J; Eriksson J; Helmfors H; Muñoz-Alarcón A; Srimanee A; Figueroa RA; Hallberg E; Ezzat K; Langel Ü
    J Control Release; 2015 May; 206():58-66. PubMed ID: 25769688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
    Lin W; Xie X; Yang Y; Liu H; Fu X; Chen Y; Liu H; Yang Y
    J Pharm Pharmacol; 2015 Sep; 67(9):1215-31. PubMed ID: 25880614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of siRNA therapeutics using cowpea chlorotic mottle virus-like particles.
    Lam P; Steinmetz NF
    Biomater Sci; 2019 Aug; 7(8):3138-3142. PubMed ID: 31257379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.